Skip to content
type1.science
N/A (device / behavioral)RecruitingNCT07593625

Next-generation Omnipod M/S AID algorithms in T1D

What this study tests

Recruiting New Zealand study evaluating investigational Omnipod M and Omnipod S automated-insulin-delivery systems in people aged 2-70 with T1D.

Editorial review: .

Registry checked: 2026-09-17. Registry’s own update: 2026-09-10.

Source dates appear in the references where available; this record has no dated citation metadata.

Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence

Full sources ↓Full discussion ↓Report an issue →

Evidence at a glance

Who can enter the study?
People aged 2-70 with T1D for at least 6 months (ages 8-70) or at least 3 months (ages 2-7), using basal-bolus insulin and judged able to operate the study devices; see registry for full criteria. Registered eligibility ↗Enrollment criteria describe who may enter. They do not establish who was analyzed or the denominator for a reported result.
Reported benefit and results
No results posted. The study started on 25 May 2026, is recruiting toward an estimated enrolment of 80 participants, and estimates primary completion on 31 December 2026.Read the result sources and their limitations →
Important harms
Read the reported results, safety discussion and original sources. A separate harms summary is not available; this does not establish safety.
Research access and approval
Study regions: Other regions. A trial listing does not establish product approval or current recruitment at a particular site. Check the study’s current entry requirements.
What remains uncertain?
Read the full discussion and original sources for study limitations. Planned endpoints and completion dates are not results.

Research status alone does not establish approval, clinical benefit or local availability.

Primary endpoints

  • Percentage of time <54 mg/dL
  • Percentage of time <70 mg/dL
  • Percentage of time >180 mg/dL

The full picture

This record has no longer discussion. Use the study criteria, reported results and original sources on this page to assess what is known and what remains unresolved.

Sources

  1. [1]
    NCT07593625: Next-generation Omnipod M/S AID algorithms in T1D · Trial registry — Registry checked 2026-08-08: RECRUITING in New Zealand, ages 2-70, estimated enrolment 80, primary completion 2026-12-31; update posted 2026-07-20.